Hijacking a chaperone: manipulation of the MHC class II presentation pathway (Q34091299)

31 July 2017

1 reference

title

Hijacking a chaperone: manipulation of the MHC class II presentation pathway (English)

1 reference

31 July 2017

0 references

Koch N

1

1 reference

31 July 2017

van Driel IR

series ordinal

2

1 reference

31 July 2017

Gleeson PA

series ordinal

3

1 reference

31 July 2017

publication date

1 November 2000

1 reference

31 July 2017

1 reference

31 July 2017

volume

21

1 reference

31 July 2017

issue

11

1 reference

31 July 2017

page(s)

546-550

1 reference

Accessory molecules for MHC class II peptide loading

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2800%2901717-5

7 January 2021

Proteolysis in MHC class II antigen presentation: who's in charge?

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2800%2901717-5

7 January 2021

Role for cathepsin F in invariant chain processing and major histocompatibility complex class II peptide loading by macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2800%2901717-5

7 January 2021

Modulation of the major histocompatibility complex class II-associated peptide repertoire by human histocompatibility leukocyte antigen (HLA)-DO.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2800%2901717-5

7 January 2021

Engineering an intracellular pathway for major histocompatibility complex class II presentation of antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2800%2901717-5

7 January 2021

Expression of endogenous peptide-major histocompatibility complex class II complexes derived from invariant chain-antigen fusion proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2800%2901717-5

7 January 2021

Cloning genes encoding MHC class II-restricted antigens: mutated CDC27 as a tumor antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2800%2901717-5

7 January 2021

Identification of a novel major histocompatibility complex class II-restricted tumor antigen resulting from a chromosomal rearrangement recognized by CD4(+) T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2800%2901717-5

7 January 2021

Endosomal proteolysis and MHC class II function

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2800%2901717-5

7 January 2021

The CLIP-substituted invariant chain efficiently targets an antigenic peptide to HLA class II pathway in L cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2800%2901717-5

7 January 2021

Positive selection of T cells induced by viral delivery of neopeptides to the thymus

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2800%2901717-5

7 January 2021

C-terminal extension of the MHC class II-associated invariant chain by an antigenic sequence triggers activation of naive T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2800%2901717-5

7 January 2021

An altered invariant chain protein with an antigenic peptide in place of CLIP forms SDS-stable complexes with class II alphabeta dimers and facilitates highly efficient peptide loading.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2800%2901717-5

7 January 2021

Efficient loading of HLA-DR with a T helper epitope by genetic exchange of CLIP.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2800%2901717-5

7 January 2021

Get into the groove! Targeting antigens to MHC class II.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2800%2901717-5

7 January 2021

Requirement for diverse, low-abundance peptides in positive selection of T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2800%2901717-5

7 January 2021

Production of soluble MHC class II proteins with covalently bound single peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2800%2901717-5

7 January 2021

The repertoire of T cells shaped by a single MHC/peptide ligand.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2800%2901717-5

7 January 2021

The central role of CD4(+) T cells in the antitumor immune response

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2800%2901717-5

7 January 2021

Therapeutic vaccination for cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2800%2901717-5

7 January 2021

Antigen-specific immunotherapy for murine lung metastatic tumors expressing human papillomavirus type 16 E7 oncoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2800%2901717-5

7 January 2021

Identification of MAGE-3 epitopes presented by HLA-DR molecules to CD4(+) T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2800%2901717-5

7 January 2021

Discrete proteolytic intermediates in the MHC class I antigen processing pathway and MHC I-dependent peptide trimming in the ER.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2800%2901717-5

7 January 2021

The evolution of self-tolerance: a new cell arises to meet the challenge of self-reactivity

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2800%2901717-5

7 January 2021

DNA vaccines: immunology, application, and optimization*

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2800%2901717-5

7 January 2021

Invariant chains with the class II binding site replaced by a sequence from influenza virus matrix protein constrain low-affinity sequences to MHC II presentation

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2800%2901717-5

7 January 2021

10.1016/S0167-5699(00)01717-5

Identifiers

DOI

1 reference

31 July 2017

1 reference